The Nrf2-Keapl defence pathway: Role in protection against drug-induced toxicity

被引:281
作者
Copple, Ian M. [1 ]
Goldring, Christopher E. [1 ]
Kitteringham, Neil R. [1 ]
Park, B. Kevin [1 ]
机构
[1] Univ Liverpool, Sch Biomed Sci, Drug Safety Res Grp, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
关键词
Nrf2; keapl; cell defence; drug-induced toxicity;
D O I
10.1016/j.tox.2007.10.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolic biotransformation of xenobiotics to chemically reactive metabolites can, in some instances, underlie the pathogenesis of certain adverse drug reactions, due to the development of chemical or oxidative stress. In order to guard against such stresses, mammalian cells have evolved multi-faceted, highly-regulated defence systems, one of the most important being that which is regulated by the transcription factor Nrf2. Through regulating the expression of numerous cytoprotective genes, Nrf2 serves as a critical determinant of a cell's capacity to survive, or succumb, to a toxic insult. The aim of this review is to summarise our current understanding of the biochemistry that underlies the Nrf2 defence pathway, and highlight the important role of this transcription factor in the protection against drug-induced toxicity, primarily through the examination ofrecent investigations that have demonstrated an increased vulnerability to various toxins in animals lacking Nrf2. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:24 / 33
页数:10
相关论文
共 156 条
[1]   Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene [J].
Alam, J ;
Stewart, D ;
Touchard, C ;
Boinapally, S ;
Choi, AMK ;
Cook, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26071-26078
[2]   Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2 [J].
Alam, J ;
Killeen, E ;
Gong, PF ;
Naquin, R ;
Hu, B ;
Stewart, D ;
Ingelfinger, JR ;
Nath, KA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (04) :F743-F752
[3]   Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust [J].
Aoki, Y ;
Sato, H ;
Nishimura, N ;
Takahashi, S ;
Itoh, K ;
Yamamoto, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 173 (03) :154-160
[4]   Enhanced spontaneous and benzo(a)pyrene-induced mutations in the lung of Nrf2-deficient gpt delta mice [J].
Aoki, Yasunobu ;
Hashimoto, Akiko H. ;
Amanuma, Kimiko ;
Matsumoto, Michi ;
Hiyoshi, Kyoko ;
Takano, Hirohisa ;
Masumura, Ken-ichi ;
Itoh, Ken ;
Nohmi, Takehiko ;
Yamamoto, Masayuki .
CANCER RESEARCH, 2007, 67 (12) :5643-5648
[5]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[6]  
BAIN J, 2007, BIOCH J 0913
[7]   Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression [J].
Bloom, DA ;
Jaiswal, AK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44675-44682
[8]   Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase [J].
Bourdi, M ;
Masubuchi, Y ;
Reilly, TP ;
Amouzadeh, HR ;
Martin, JL ;
George, JW ;
Shah, AG ;
Pohl, LR .
HEPATOLOGY, 2002, 35 (02) :289-298
[9]   Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound [J].
Braun, S ;
Hanselmann, C ;
Gassmann, MG ;
Keller, UAD ;
Born-Berclaz, C ;
Chan, KM ;
Kan, YW ;
Werner, S .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5492-5505
[10]   Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription [J].
Calkins, MJ ;
Jakel, RJ ;
Johnson, DA ;
Chan, KM ;
Kan, YW ;
Johnson, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (01) :244-249